Literature DB >> 28292503

Opioids, naloxone, and beyond: The intersection of medication safety, public health, and pharmacy.

Jeffrey P Bratberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28292503     DOI： 10.1016/j.japh.2017.02.006

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN： 1086-5802


× No keyword cloud information.
  4 in total

1.  Community pharmacies as access points for addiction treatment.

Authors:  Kevin A Look; Mercedes Kile; Katie Morgan; Andrew Roberts
Journal:  Res Social Adm Pharm       Date:  2018-06-12

2.  Pharmacists' role in harm reduction: a survey assessment of Kentucky community pharmacists' willingness to participate in syringe/needle exchange.

Authors:  Amie Goodin; Amanda Fallin-Bennett; Traci Green; Patricia R Freeman
Journal:  Harm Reduct J       Date:  2018-01-25

3.  Pharmacists and opioid use disorder care during COVID-19: Call for action.

Authors:  Insaf Mohammad; Dena Berri; Victoria Tutag Lehr
Journal:  J Am Coll Clin Pharm       Date:  2021-11-08

4.  Differences in cue-induced brain activation between long-term methadone maintenance treatment and protracted abstinence in heroin use disorder patients: a functional magnetic resonance imaging study.

Authors:  Xuan Wei; Qiang Li; Jiajie Chen; Baorui Shen; Wei Wang; Wei Li
Journal:  Quant Imaging Med Surg       Date:  2021-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.